We are a biotechnology
company that creates
revolutionary health treatments
based on the use of genetically
engineered viruses.
Home2022-11-28T23:37:56-03:00

From enemy
to hero.

Watch the video and discover how Vyro is transforming the scourge of the Zika virus into revolutionary treatments.

Pipeline

Press

About us

Our team is made up of professionals specialized in several areas who have the same mission: to create innovative treatments for the greatest challenges of human health.
We invite you to learn more about our team and see who is behind our success and efficiency.

Board of Directors

KEITH OKAMOTO

KEITH OKAMOTO

Cofounder and Board Member

Associate Professor at the University of Sao Paulo (USP) and Principal Researcher at The Human Genome and Stem Cell Research Center (HUG-CELL) at USP, where he directs the Translational Genomics Laboratory since 2010. Using a multidisciplinary approach, his research has contributed to a better understanding of the molecular mechanisms that regulate stem cell self-renewal, differentiation, and contribution to the development of cancer.

GABRIEL BOTTOS

GABRIEL BOTTOS

Co-founder and Member of the Board of Directors

Gabriel graduated in production engineering at the University of Santa Catarina (south). Co-founder and CEO at Vesper Ventures SA, a biotech venture builder fund, where he participates at the board of several startups focused on therapies, diagnostics, agriculture and environment. Previously he co-founded companies such as Welle Laser SA, Exact Sales and GnTech. He is a member of Endeavor and Board of Trustees member at the Fraunhofer Project Center for Adva...

Ver mais

Scientific Advisory Board

ERNESTO GOULART

ERNESTO GOULART

Co-founder and Scientific Consultant

Entrepreneur-scientist. Ph.D. and MSc in Genetics graduated from The University of Sao Paulo and UFJF/Temple University - USA. Serial entrepreneur, Co-founder of biotech startups. Scientific advisor, and consultant. Has been working for 15 years in developing advanced therapy and bioengineering products and companies. Expert in genetic engineering using the CRISPR-Cas9 system, stem cells, regenerative medicine, and tissue engineering (e.g. 3D bioprinting, or...

Ver mais

LUIZ CAIRES

LUIZ CAIRES

Co-founder and Scientific Advisor

Research scientist and entrepreneur, MBA in Business Management (University of Sao Paulo / Esalq), FEA Angels Associate. He is one of the founding scientists of the line of research and development of medical technologies with Zika virus at The Human Genome and Stem Cell Research Center (HUG-CELL) of the University of Sao Paulo, which began in 2015, and the study of the oncolytic effects of the Zika virus on central nervous system (CNS) tumors.

MAYANA ZATZ

MAYANA ZATZ

Co-founder and Scientific Advisor

Mayana Zatz is a Brazilian molecular biologist and geneticist, professor at the Department of Genetics and Evolutionary Biology at the Institute of Biosciences at the University of Sao Paulo (USP). She held the position of Dean of Research at USP from 2005 to 2009. Researcher in human genetics with contributions mainly in the field of neuromuscular diseases (muscular dystrophies, spastic paraplegias, amyotrophic lateral ese) in which she is a pioneer. Cu...

Ver mais

Team

CAROLINI KAID, PHD

CAROLINI KAID, PHD

Cofounder and Chief Scientific Officer

Completing 10 years of research experience in the field of cancer biology and genetics. Graduated in Biological Sciences from the University of Sao Paulo (2012). She was the first author of the two breakthrough publications on preclinical studies with the oncolytic Zika virus. She continues to investigate alternative immunotherapies focusing on oncolytic viruses.

HUGO CABRERA

HUGO CABRERA

Co-founder

Biotechnology entrepreneur with a passion for R&D and innovation in the field of cell and gene therapy. Previous founder of clinical-stage cell therapy company in the regenerative medicine space, whose technology and IP were licensed to global medical device corporation. Experienced in licensing deals, tech transfer, company creation, fundraising and business development of advanced therapy medicinal products (ATMPs). At Vyro Biotherapeutics, he has sign...

Ver mais

MAURICIO MEROS

MAURICIO MEROS

Chief of Operations

Mauricio Meros has a degree in Chemical Engineering, He has a 24 years of pharmaceutical and biological manufacturing, development, process and engineering, Former Director of the Division of Technological Development and Production of Instituto Butantan where he was also Director of the Division of Engineering and Architecture, President of the Brazilian Society of Contamination Control [SBCC].

GABRIELA NOVAES, PHD

GABRIELA NOVAES, PHD

Scientist, Oncology

Gabriela Novaes received her PhD from the school of Pharmaceutical Sciences at the University of Sao Paulo. She is specialized in molecular oncology with a focus in microRNAs. Currently, Gabriela is the scientist responsible for preclinical in vitro tests that guarantee the safety and effectiveness of the products developed by Vyro Biotherapeutics.

CÉZAR SANTOS

CÉZAR SANTOS

Assistant Manager in the Company's Quality Sector

Cézar Santos is a undergraduate student in biological sciences, that started working with the oncolitic effects of the ZIKV in 2021 in the Human Genome and Stem Cell Research Center of the University of Sao Paulo, where he works on his scientific initiation with the objective to investigate and characterize the direct and indirect effects of the ZIKV infection in different tumors of the Center Nervous System (CNS). In 2022, he started working for Vyro Biothe...

Ver mais

GIOVANNA OLBERG, B.SC

GIOVANNA OLBERG, B.SC

Lab technician, Cell Biology

Giovanna Olberg, Biologist with a postgraduate degree in Health Services Management, has experience in Cell Biology, Molecular Biology and Human Genetics from the Human Genome and Stem Cell Research Center (HUG-CELL) of the University of Sao Paulo. At Vyro Biotherapeutics, she’s responsible for maintaining cell culture.

PEDRO MACHADO

PEDRO MACHADO

Scientist, Vector Engineering, Biotechnologist

Pedro is responsible for the creation and development of strategies for gene therapy vectors employing the Zika virus. He’s also responsible for the execution of the oncolytic virus platform. Pedro graduated from the Federal University of Uberlandia with a bachelor's degree in biotechnology. He completed his scientific initiation in the fields of biochemistry, bioprocesses, and fermentative processes. While on exchange in Portugal, he worked as a researcher ...

Ver mais

DIEGO MODOLO, PHD

DIEGO MODOLO, PHD

Scientist, Gene Therapy Vector Engineering

Diego Grando Modolo graduated in Biological Sciences and has a master’s degree and PhD in Genetics and Molecular Biology from State University of Campinas (UNICAMP). Diego has more than 17 years of experience in DNA vector design and recombinant protein expression, purification, and characterization. Since graduating, Diego has worked in DNA vector design and the production of recombinant proteins in plants and bacteria. As a Postdoctoral Researcher, Diego ...

Ver mais

CARLA LONGO, PHD

CARLA LONGO, PHD

Scientist, Virology & Immunology

Carla Longo is a biologist graduated from the Federal University of Sao Paulo (UNIFESP), has a master's degree in Immunology from the same University, and doctorate degree in Immunology from the University of Sao Paulo. During her PhD, Carla studied neuro immunology and investigated how Zika virus infection impacts central nervous system development and causes severe neurological diseases. She also participated in studies with dengue virus. Then, she conduct...

Ver mais

THAIS PERON

THAIS PERON

Scientist, Quality

Thais Peron is a master’s degree student at the Institute of Biomedical Sciences at the University of Sao Paulo, where she specialized in Plasmodium molecular genetics, with focus in drug discovery. Currently, Thais is the scientist responsible for quality management, assuring the excellence of the processes and products produced by Vyro Biotherapeutics.

CAROLINE LIMA, MSC

CAROLINE LIMA, MSC

Scientist, Molecular Biology

Caroline Lima, graduate in biomedicine and master’s degree in biotechnology with an emphasis on bioproducts and bioprocesses from the Federal University of Sao Paulo (UNIFESP). Her career began in scientific initiation during graduation, where she worked with cloning, expression of heterologous proteins and other recombinant DNA technologies. During her master's degree, she worked with conditional gene expression and IC50 methodologies. Currently, Caroline i...

Ver mais

FLÁVIA SANTORO

FLÁVIA SANTORO

Marketing assistant

Biomedical Sciences undergraduate student at the Institute of Biomedical Sciences of the University of Sao Paulo (ICB/USP). Co-founder of the Instagram account @ocienciaetal and co-founder of the 1st League of Scientific Communication at USP. Lecturer on immunology in 2 editions of USP-Escola, in 2021 and 2022. She is currently a marketing assistant at Vyro Biotherapeutics.

Go to Top